Glomerular Filtration Rate Determination Using Iohexol Plasma Disappearance versus Iothalamate Renal Clearance

Overview

About this study

The goal of this study is to evaluate the glomerular filtration rate determination using plasma disappearance of Iohexol and determine its clinical validity in comparison with the current standard Iothalamate renal clearance.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age more than 18 years

Exclusion Criteria:

Patients with moderate to severe allergies to iodinated contrast (defined below)
Pregnant and Breastfeeding patients
Patients that refuse placement of a urinary catheter, if they have significant residual urine after 2-3 attempts of voiding.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Timothy Larson, M.D.	Closed for enrollment	Contact information: Maria Stevens (507)422-5992 Stevens.Maria@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Timothy Larson, M.D.

Closed for enrollment

Contact information:

Maria Stevens

(507)422-5992

Stevens.Maria@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials